[1]方邦江,邬鑫鑫 张文 曹敏 郭全 黄廷荣 周爽 李金花 任毅7 邵忠8 彭伟 刘力.基于中医疫病理论之“表里双解”截断扭转法治疗新冠肺炎的理论与实践[J].陕西中医药大学学报,2022,(04):001-7.[doi:10.13424/j.cnki.jsctcm.2022.04.001]
　FANG Bangjiang,WU Xinxin ZHANG Wen CAO Min GUO Quan HUANG Tingrong ZHOU Shuang LI Jinhua REN Yi7 SHAO Zhong8 PENG Wei LIU Li.Theory and Practice of COVID-19 Treatment with Truncation and Reverse “Resolving Both Exterior and Interior” Method Based on TCM Epidemic Theory[J].Journal of Shaanxi University of Traditional Chinese Medicine,2022,(04):001-7.[doi:10.13424/j.cnki.jsctcm.2022.04.001]
点击复制

基于中医疫病理论之“表里双解”截断扭转法治疗新冠肺炎的理论与实践
分享到：

《陕西中医药大学学报》[ISSN:2096-1340/CN:61-1501/R]

卷:
期数:
2022年04期
页码:
001-7
栏目:
疫病防治
出版日期:
2022-07-20

文章信息/Info

Title:
Theory and Practice of COVID-19 Treatment with Truncation and Reverse “Resolving Both Exterior and Interior” Method Based on TCM Epidemic Theory
文章编号:
2096-1340(2022)04-0001-07
作者:
方邦江1; 2; 3; 邬鑫鑫1 张文1 曹敏1 郭全1 黄廷荣4 周爽5 李金花6 任毅7 邵忠8 彭伟1 刘力3
1.上海中医药大学附属龙华医院，上海 200032；
2.上海中医药大学急危重病研究所，上海 201203；
3.陕西中医药大学疫病研究院，陕西 咸阳 712046；
4.黄石市中医医院（市传染病医院）， 湖北 黄石435000；
5.上海中医药大学，上海 201203；
6.九江市中医医院，江西 九江332000；
7.重庆市中医院，重庆 400021；
8.抚顺市第三医院，辽宁 抚顺 113004
Author(s):
FANG Bangjiang1; 2; 3; WU Xinxin1 ZHANG Wen1 CAO Min1 GUO Quan1 HUANG Tingrong4 ZHOU Shuang5 LI Jinhua6 REN Yi7 SHAO Zhong8 PENG Wei1 LIU Li3
关键词:
关键词：疫病; 新冠肺炎; 表里双解; 截断扭转; 中医药
Keywords:
Key words： Epidemic disease; COVID-19; Resolving both exterior and interior;  Truncation and reverse;  Traditional Chinese Medicine
分类号:
R254.3?
DOI:
10.13424/j.cnki.jsctcm.2022.04.001
文献标志码:
A
摘要:
摘 要：新冠肺炎属于中医学“疫病”范畴，根据中医疫病理论，在传承《温疫论》等中医药治疗传染病理论基础上，并借鉴国医大师朱良春教授和国医大师晁恩祥教授治疗传染病的学术经验，针对新冠肺炎中医证候特点，在2020年新冠肺炎爆发之初即提出“表里双解”之截断扭转法治疗新冠肺炎的学术观念，倡导以化湿透表泻毒和清热利湿泻毒之“表里双解”，以截断扭转新冠病毒感染患者病势，通过武汉、上海疫情爆发期间新冠肺炎定点医院治疗轻症、普通型新冠肺炎结果显示，该疗法在缩短患者核酸转阴时间、阻断新冠肺炎向重症、危重症转化效果显著，为当今中医药治疗新冠肺炎和未来防治新发突发传染病提供了新的思路。
Abstract:
Abstract： COVID19 belongs to the category of “epidemic disease” in traditional Chinese medicine. According to the epidemic disease theory of traditional Chinese medicine, on the basis of inheriting the theory of treating infectious diseases with traditional Chinese medicine such as the theory of febrile disease, and drawing lessons from the academic experience of treating infectious diseases of professor ZHU Liangchun and Professor CHAO Enxiang, both masters of traditional Chinese medicine, and aiming at the characteristics of TCM Syndromes of COVID19, at the beginning of the outbreak of COVID19 in 2020, the academic concept of “resolving both exterior and interior” for the treatment of COVID19 was put forward, and the “resolving both exterior and interior” of “eliminating dampness through the surface and purging toxin” and “clearing heat and diuresis” were advocated to cut off and reverse the disease of patients infected with COVID19. The results of treatment of mild and common COVID19 in COVID19 designated hospitals during the outbreak of the epidemic in Wuhan and Shanghai showed that this treatment could shorten the time of nucleic acid negative transformation of patients,blocking the transformation of COVID19 to severe and critical diseases has a significant effect, which opens up a new idea for the treatment of COVID19 with traditional Chinese medicine and the prevention and treatment of new sudden infectious diseases in the future.

参考文献/References:

［1］World Health Organization.Coronavirus disease (COVID19) situation reports［EB/OL］.(2022-05-31)［2021-05-31］.https://covid19.who.int/.
［2］国家卫生健康委员会.新型冠状病毒肺炎诊疗方案（试行第九版）［EB/OL］.(2022-03-15)［2022-03-15］.http://www.nhc.gov.cn/yzygj/s7653p/202203/b74ade1ba 4494583805a3d2e40093d88/files/ef09aa4070244620b010951b088b8a27.pdf.
［3］方邦江,齐文升,黄烨.新型冠状病毒感染的肺炎中西医结合防控手册［M］.北京:人民卫生出版社,2020:65-67.
［4］Fang BJ,Zhang W,Wu XX,et al.Shenhuang granule in the treatment of severe coronavirus disease 2019 (COVID-19):study protocol for an openlabel randomized controlled clinical trial［J］.Trials,2020,21(1):568.
［5］Wu XX,Lu W,Guo Q,et al.Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on “Internal and External RelievingTruncated Torsion” strategy［J］.Medicine,2020,99(51):e23874.
［6］方邦江,李灿辉,陈业孟,等.中医疫病学实践和理论的发展创新:中外专家谈新型冠状病毒肺炎中医治疗启示［J］.中国中西医结合杂志,2020,40(11):12851290.
［7］Wu XX,Zhou S,Liu CY,et al.Clinical predictive risk factors prolonged the duration of SARS-CoV-2 clearance in 279 moderate COVID-19 patients:a multicenter retrospective cohort study［J］.Medicine,2021,100(40):e27410.
［8］包兆含,张文,邬鑫鑫,等.“截断扭转扶正固本”法治疗疫病思想对新型冠状病毒肺炎救治的启示［J］.中国中医急症,2020,29(8):1320-1322.
［9］方邦江,齐文升,杨志旭,等.《新型冠状病毒肺炎诊疗方案(试行第九版)》中医治疗更新及其对奥密克戎变异株感染防治指导作用［J］.陕西中医药大学学报,2022,45(3):1-4.
［10］吴有性.温疫论［M］.北京: 中国医药科技出版社，2018．
［11］王孟英.温热经纬［M］.北京: 人民卫生出版社，2005．
［12］杨璇.伤寒温疫条辨［M］.北京: 学苑出版社，2006.
［13］吴鞠通.温病条辨［M］．北京：学苑出版社，2017.
［14］方邦江,周爽.国医大师朱良春治疗疑难危急重症经验集［M］.北京:中国中医药出版社,2013.
［15］方邦江,张洪春.国医大师晁恩祥治疗危急疑难重症学术经验［M］.北京:人民卫生出版社,2020.
［16］van Eijk LE,Binkhorst M,Bourgonje AR,et al.COVID19:immunopathology,pathophysiological mechanisms,and treatment options［J］.The Journal of Pathology,2021,254(4):307-331.
［17］方邦江,张文,周爽,等.基于“急性虚证”理论防治新型冠状病毒肺炎探析［J］.中医杂志,2021,62(9):826-828.
［18］Zhou S,Feng J,Xie Q,et al.Traditional Chinese medicine Shenhuang Granule in patients with severe/critical COVID19:a randomized controlled multicenter trial［J］.Phytomedicine,2021,89:153612.
［19］鲍建敏.基于“肺与大肠相表里”再认识的新型冠状病毒肺炎治疗［J］.浙江中医药大学学报,2020,44(6):500-506.
［20］陈晓蓉,方邦江.中西医结合诊疗新型冠状病毒肺炎验案120例［M］.上海:上海科学技术出版社,2020.
［21］中国国家卫生健康委员会.新型冠状病毒肺炎诊疗方案(试行第九版)［J］.国际流行病学传染病学杂志,2022,49(2):73-80.
［22］方邦江,苏红,赵软金,等.新型冠状病毒奥密克戎变异株感染中医药防治专家共识［J］.中国急救医学,2022,42(4):277-280.
［23］周选堂.时病论歌括新编［M］.武汉:湖北科学技术出版社,1987.
［24］周爽,卜建宏,孙丽华.方邦江治疗急重疑难病证学术经验［M］.北京:中国中医药出版社,2018:27-28.
［25］张向红,程黎晖.大黄的药理作用及临床应用研究进展［J］.中国药业,2009,18(21):76-78.
［26］王琳,王丽,吴建鹏,等.大黄治疗危重症胃肠功能受损患者的疗效观察［J］.中国中医急症,2021,30(10):1805-1808.
［27］Keser S,Keser F,Karatepe M,et al.Bioactive contents,in vitro antiradical,antimicrobial and cytotoxic properties of rhubarb (Rheum ribes L.) extracts［J］.Natural Product Research,2019,34(23):3353-3357.
［28］王志洁,邓培,方学韫,等.虎杖蒽醌化合物抗疱疹病毒的实验研究［J］.湖北医科大学学报,2000,21(3):180-183.
［29］谢扬,张勇,刘瑞源.虎杖及其复方制剂抗病毒有效成分研究与临床应用［J］.时珍国医国药,2004,15(8):527.
［30］邓艳,刘洪,吴新玉,等.虎杖苷的保肝作用研究进展［J］.中国比较医学杂志,2021,31(9):136-140.
［31］李志军.“三证三法”及“菌毒炎并治”治疗脓毒症的研究进展［J］.中国中西医结合外科杂志,2012,18(6):553-554.
［32］牛颖,章学林,方邦江,等.锦红汤对急性胆源性感染全身性炎症反应综合征的调节作用［J］.中国中西医结合杂志,2004,24(8):707-709.
［33］朱玲,赵平,李萍,等.加味锦红汤联合西医常规疗法治疗脓毒症临床研究［J］.上海中医药杂志,2014,48(10):57-59.
［34］黄明,杨丰文,张磊,等.中医药治疗新型冠状病毒肺炎的经验与策略:张伯礼院士武汉一线抗疫思考［J］.中医杂志,2020,61(24):2117-2120.

相似文献/References:

[1]杨璞叶,黄小正,杨明博,等.从病理学角度探讨清肺排毒汤联合克力芝治疗新冠肺炎的优势[J].陕西中医药大学学报,2020,(预出版):024.
　Yang Puye,Huang Xiaozheng,Yang Mingbo,et al.Advantages of novel coronavirus pneumonia treated by Qingfei Detox Soup combined with Lopinavir and Ritonavir Tablets from the perspective of pathology[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):024.
[2]魏耕树 朱恩林 王欣 王卓.益气宣痹汤治疗新冠肺炎后肺纤维化倾向可行性探讨[J].陕西中医药大学学报,2020,(预出版):036.
　Gengshu Wei,Enlin Zhu,Xin Wang,et al.Feasibility of Yiqi Xuanbi Decoctionin treating pulmonary fibro - sisafter new crown pneumonia[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):036.
[3]赵晓平 昝强 范小璇** 董盛 孙建飞 周振国 杨磊 岳黎明 王建丽 杨志霈.陕西中医药大学附属医院抗击新冠肺炎疫情“4+4”模式**[J].陕西中医药大学学报,2020,(预出版):061.
　Xiaoping Zhao,Qiang Zan,Xiaoxuan Fan*,et al.Follow the Pattern of 4+4 to Prevention and Control Novel Coronavirus Pneumonia(NCP) in Affiliated Hospital of Shaanxi University of Chinese Medicine[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):061.
[4]赵晓平 昝强 范小璇 董盛 孙建飞 周振国 杨磊 岳黎明 王建丽 杨志霈.陕西中医药大学附属医院抗击新冠肺炎疫情“4+4”模式[J].陕西中医药大学学报,2020,(02):008.[doi:10.13424/j.cnki.jsctcm.2020.02.003]
　Zhao Xiaoping,Zan Qiang,Fan Xiaoxuan,et al.The 4 +4 Pattern to Prevent and Control Coronavirus Disease 2019 in Affiliated Hospital of Shaanxi University of Chinese Medicine[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):008.[doi:10.13424/j.cnki.jsctcm.2020.02.003]
[5]辛宝胡晗祁乐周海哲.和而不同——从疫病防治看治未病和传统预防医学的区别与联系[J].陕西中医药大学学报,2020,(02):013.[doi:10.13424/j.cnki.jsctcm.2020.02.004]
　Xin Bao,Hu Han,Qi Le,et al.Difference and Connection between Preventative Treatment of Disease and Traditional Preventative Medicine from Epidemic Prevention and Treatment - Unity without Uniformity[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):013.[doi:10.13424/j.cnki.jsctcm.2020.02.004]
[6]杨璞叶 黄小正 杨明博 张鑫.从病理学角度探讨清肺排毒汤联合克力芝治疗新冠肺炎的优势[J].陕西中医药大学学报,2020,(03):001.[doi:10.13424/j.cnki.jsctcm.2020.03.001]
　Yang Puye,Huang Xiaozheng,Yang Mingbo,et al.Advantages of novel coronavirus pneumonia treated by Qingfei Detox Soup combined with Lopinavir and Ritonavir Tablets from the perspective of pathology[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):001.[doi:10.13424/j.cnki.jsctcm.2020.03.001]
[7]魏耕树朱恩林 王欣 王卓.益气宣痹汤治疗新冠肺炎后肺纤维化倾向可行性探讨[J].陕西中医药大学学报,2020,(5):007.[doi:10.13424/j.cnki.jsctcm.2020.05.002]
　Wei Gengshu,Zhu Enlin,Wang Xin,et al.Feasibility of Yiqi Xuanbi Decoction in the Treatment of Post - Covid19 Pulmonary Fibrosis[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(04):007.[doi:10.13424/j.cnki.jsctcm.2020.05.002]
[8]崔晋伟 张晓梅,杨华升 赖宇鑫 刘彧杉 于小林 姜良铎.姜良铎从急性虚损辨治新型冠状病毒肺炎探讨[J].陕西中医药大学学报,2021,44(01):010.[doi:10.13424/j.cnki.jsctcm.2021.01.002]
　CUI Jin - wei,ZHANG Xiao - mei,YANG Hua - sheng,et al.Discussion on the Treatment of COVID-19 from the Pespective of Acute Insufficiency Differentiation Syndrome by JIANG Liang-duo[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(04):010.[doi:10.13424/j.cnki.jsctcm.2021.01.002]
[9]康艳 李耀辉** 薛敬东 刘伊莎.基于脏腑相关理论之肺脾相关分析新冠肺炎的病位[J].陕西中医药大学学报,2021,44(03):005.[doi:10.13424/j.cnki.jsctcm.2021.03.002]
[10]曹雪 蒲秀玲 刘小莹 彭红侠 郭团茂 张晓妮.陕西咸阳地区新型冠状病毒肺炎患者中医临床特征分析[J].陕西中医药大学学报,2021,44(04):001.[doi:10.13424/j.cnki.jsctcm.2021.04.001]
　CAO Xue PU Xiuling LIU Xiaoying PENG Hongxia GUO Tuanmao ZHANG Xiaoni.Clinical Characteristics of COVID-19 Patientsin Xianyang District of Shaanxi[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(04):001.[doi:10.13424/j.cnki.jsctcm.2021.04.001]

备注/Memo

备注/Memo:
基金项目：国家重点研发计划（2018YFC1705900）；上海市科学技术委员会科研计划项目（19401933300）；国家中医药管理局2022年第五批新型冠状病毒感染肺炎中医药应急专项课题（2022ZYLCYJ05-4）；上海中医药大学2022年度应对奥密克戎感染新型冠状病毒（2022YJ-03、2022YJ-06）
更新日期/Last Update: 2022-07-25